AAL Short Sellers Ease Back as Analyst Targets Keep Falling

American Airlines enters November in an uncomfortable position: short interest remains heavy at 15% of the free float, the analyst community has spent the past month cutting targets, and the stock at $12.82 is running well below what even the more cautious bulls think it is worth.

Short positioning is the clearest structural fact about AAL right now. At 15% of free float, bears hold a meaningful stake in the outcome, though the direction of travel this week has shifted. Short interest fell roughly 4% over the past five days to 99 million shares, pulling back from a peak of around 104 million shares in late October. That monthly increase of 14% tells the broader story: shorts built aggressively through October before trimming slightly into November. Borrow costs remain low at 0.43%, well within normal territory, and availability has actually loosened considerably. With availability at 534% of short interest, there are more than five shares available to borrow for every share currently shorted. That is comfortably above the year's tightest reading of 342% and leaves no sign of squeeze pressure in the lending market. Options confirm the cautious but not panicked tone: the put/call ratio at 1.58 sits modestly above its 20-day average of 1.53, roughly 0.9 standard deviations above the mean, well below the 52-week high of 2.41 that marked the most defensive period of the past year. Positioning looks bearish but not extreme.

The analyst picture is uniformly grim in direction, if not in destination. Every firm that updated its view between late September and late October cut its price target, with no upgrades and no new initiations. Morgan Stanley maintained its Overweight rating last week but trimmed the target from $24 to $22, the highest remaining target on the Street. Goldman Sachs sits at the other end with a Sell and an $11 target, implying downside from current levels. The consensus mean of $15.39 still represents nearly 20% upside from $12.82, but that gap has been narrowing as targets converge downward. On valuation, the EV/EBITDA of 7.1x has expanded slightly over 30 days despite a weaker stock, as EBITDA estimates have been revised down faster than the share price has fallen. The P/E at 21.4x has ballooned over the same period, up more than 11 turns in 30 days, reflecting deteriorating near-term earnings momentum. ORTEX factor scores put EPS momentum in the 1st percentile over 30 days and the 3rd percentile over 90 days: estimates have been moving sharply in the wrong direction.

The real-economy traffic data offers some balance. BTS figures from the Bureau of Transportation Statistics show T-100 passengers carried by US airlines has risen for three consecutive months, reaching 15.76 million in July. None of the alternative datasets covering AAL carry a measured lead against its reported financials, so these figures describe the demand environment rather than the next earnings print. Still, a three-month streak of passenger growth is a constructive backdrop for the sector, even as the market focuses more on cost and debt dynamics at AAL specifically.

The most prominent institutional development in the 13D/G register is PRIMECAP Management, which raised its stake from 7.52% to 10.46% as of its June 2026 amendment, making it the largest declared holder on the register. BlackRock filed an amendment in late October confirming a 9.4% position. No 13D activist appears on the register. All positions are as last disclosed around the 5% threshold and holders dropping below that level may not file again. The insider record, meanwhile, is entirely one-directional: the most recent Form 4 activity from September shows CEO Robert Isom and Vice Chair Stephen Johnson surrendering shares under tax withholding transactions, code "F" rather than open-market sales. The 90-day net across all transaction types is a disposal of 355,000 shares valued at approximately $5.7 million, though the tax withholding nature of the September activity reduces the informational weight of that figure.

The next earnings event is not until January 27, 2027, leaving 84 days for the narrative to develop. The last quarterly print in October produced a 1% one-day decline, followed by a 4.5% five-day recovery, a pattern worth noting given how negatively the stock has been pre-positioned heading into results. For now, the two things worth watching are whether shorts continue to ease their positions after October's build, and whether the target-cutting cycle from analysts has run its course or has further to go as the Q4 period gets underway.